ClinicalTrials.gg
Not yet recruitingNCT07601633Updated May 22, 2026

Split-Belt Gait Retraining in Subacute Stroke

An interventional study of Split-belt walking training in Stroke, sponsored by University of British Columbia. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Stroke by University of British Columbia — 3 open to participants now, 4 under way, none of them phase 3. Stroke · University of British Columbia.

Planned enrollment
19th of 25
30 · median 62
Started
2026
the only one that year
No phase
24 of 30
3 open now
Registered
30th of 30
by date

Among the 30 studies in Stroke by University of British Columbia, this one is the 19th largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2026, is one of 24 with no phase, and was the 30th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

3 of the 30 studies in Stroke by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Stroke by University of British Columbia, or all of them as a file.
02

Study summary

Stroke is a leading cause of long-term disability in adults. Although many individuals regain independent walking ability following stroke, nearly 50% experience persistent gait impairments characterized by asymmetrical walking patterns, slower walking speed, impaired balance, and increased fall risk. These persistent mobility limitations highlight the continued need for innovative rehabilitation strategies that improve gait function during stroke recovery. Split-belt treadmill walking (SBTW), in which each leg walks at a different belt speed, has demonstrated potential to improve step length symmetry in individuals with chronic stroke. However, the effects of SBTW during the subacute stage of stroke recovery, within the first 9 months post-stroke when neuroplasticity may be heightened, remain largely unknown. In addition, previous SBTW studies have not integrated active physiotherapist-led gait retraining into the intervention, despite physiotherapist-led gait rehabilitation representing standard clinical care following stroke. The purpose of this randomized controlled trial is to compare physiotherapist-led gait retraining using a traditional treadmill training protocol to physiotherapist-led gait retraining integrated with a split-belt treadmill training protocol during the first 9 months post-stroke. The study aims to examine the effectiveness of the use of split-belt treadmill training to augment physiotherapist-led gait retraining to improve between-leg gait symmetry and overground walking speed.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • split-belt walking
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • unilateral stroke resulting in hemiparesis
  • less than 9 months post-stroke
  • ability to walk ten metres with or without walking aids
  • ability to stand without support for five minutes
  • English speaking

Exclusion criteria

Exclusion Criteria:

  • medically unfit to participate e.g. cardiac or respiratory disease limiting ability to perform walking tasks
  • neuromuscular impairment, other than stroke, limiting mobility, e.g. ankle sprain, joint disease such as severe arthritis
  • cognitive/communication impairment impacting ability to follow instructions
  • diagnosis of clinical depression or anxiety disorders requiring medication
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Split-belt treadmill training

    Participants will complete 12 gait training sessions over 4 weeks (3 sessions/week) on an instrumented split-belt treadmill involving both split-belt and tied-belt walking conditions. A physiotherapist will provide gait retraining during each training session.

    Behavioral: Split-belt walking training

  • No intervention
    Traditional treadmill training

    Participants will complete 12 gait training sessions over 4 weeks (3 sessions/week) on an instrumented treadmill under tied-belt walking conditions only. A physiotherapist will provide gait retraining during each training session.

Interventions

  • BehavioralSplit-belt walking training

    Participants randomized to the split-belt training group will complete 12 sessions of split-belt treadmill walking training over 4 weeks, delivered 3 times per week. Training will be performed on an instrumented split-belt treadmill and will include split-belt and tied-belt walking conditions. A physiotherapist will provide gait retraining during each session.

06

What researchers measure

Primary outcomes

  1. Step length symmetry

    Time frame: Baseline, immediately post-intervention, and at 1-month follow-up

  2. Self-selected gait speeds

    Self-selected gait speeds at both comfortable and fast speed will be measured by overground 10 meter walk tests

    Time frame: Baseline, immediately post-intervention, and at 1-month follow-up

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — IPD that underlie results in a publication will be shared.

Supporting information: Study protocol

Time frame: Beginning 3 months and ending 3 years after the publication of results

Access criteria: The PI will accept a proposal that describes planned analyses and assess the need for a data sharing agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for Jan 2029, 31 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 31 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
May 15, 2026
First posted
May 22, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
Jan 1, 2029
CompletionEst.
Jul 1, 2029
Last update
May 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07601633
Responsible party
Courtney Pollock (Assistant Professor, University of British Columbia) — Principal investigator
First posted
May 22, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Jan 1, 2029 (estimated)
Completion
Jul 1, 2029 (estimated)
Last update
May 22, 2026

Study contacts

Courtney Pollock, PT PhD
Contact
courtney.pollock@ubc.ca
604-714-4117
Beier Lin
Contact
beierlin@student.ubc.ca

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion